
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
Current cancer antigen 125 (CA-125) thresholds may miss racially and ethnically diverse patients with ovarian cancer, resulting in delayed chemotherapy initiation, according to a study published in JAMA Network Open.1 CA-125, a protein produced by ovarian …